Eli Lilly gets FDA approval for new obesity drug
November 08, 2023 at 13:22 PM EST
Zepbound helped patients lose up to 48 pounds on average in clinical trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.